Add to ORKGFrom palliative to curative treatment-stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case repor
The administration of approved systemic treatments for advanced hepatocellular carcinoma (HCC) is li...
The clinical management of frail, elderly patients affected by colorectal cancer (CRC) remains a sub...
Adrenocortical carcinoma (ACC) is a rare neoplasm characterized by poor prognosis. First-line system...
Background: Mucinous adenocarcinoma (MAC) represents 6-19 % of all colorectal carcinoma. It is assoc...
Copyright © 2014 Christos Kalaitzis et al. This is an open access article distributed under the Crea...
A rare case of primary appendiceal mucinous adenocarcinoma is reported. The presenting signs and sym...
In recent years, metronomic chemotherapy, consisting of continuous administration of low doses of cy...
Abstract Background Hepatocellular carcinoma (HCC) is one of the most frequent causes of cancer-rela...
Abstract Background A primary pulmonary invasive mucinous adenocarcinoma (IMA) is a rare subtype of ...
none7PURPOSE: We investigated the efficacy and toxicity of metronomic capecitabine administered at ...
Adrenocortical carcinoma (ACC) is a rare neoplasm characterized by poor prognosis. First-line system...
Introduction Advanced urachal carcinoma has a poor prognosis; however, a standard systemic treatment...
Mucinous adenocarcinoma of the bladder associated with long term suprapubic tube: a case repor
none7BACKGROUND: Hepatocellular carcinoma (HCC) is a highly vascular tumor which is poorly responsiv...
Background Antiangiogenic agents have established efficacy in the treatment of metastatic colorec...
The administration of approved systemic treatments for advanced hepatocellular carcinoma (HCC) is li...
The clinical management of frail, elderly patients affected by colorectal cancer (CRC) remains a sub...
Adrenocortical carcinoma (ACC) is a rare neoplasm characterized by poor prognosis. First-line system...
Background: Mucinous adenocarcinoma (MAC) represents 6-19 % of all colorectal carcinoma. It is assoc...
Copyright © 2014 Christos Kalaitzis et al. This is an open access article distributed under the Crea...
A rare case of primary appendiceal mucinous adenocarcinoma is reported. The presenting signs and sym...
In recent years, metronomic chemotherapy, consisting of continuous administration of low doses of cy...
Abstract Background Hepatocellular carcinoma (HCC) is one of the most frequent causes of cancer-rela...
Abstract Background A primary pulmonary invasive mucinous adenocarcinoma (IMA) is a rare subtype of ...
none7PURPOSE: We investigated the efficacy and toxicity of metronomic capecitabine administered at ...
Adrenocortical carcinoma (ACC) is a rare neoplasm characterized by poor prognosis. First-line system...
Introduction Advanced urachal carcinoma has a poor prognosis; however, a standard systemic treatment...
Mucinous adenocarcinoma of the bladder associated with long term suprapubic tube: a case repor
none7BACKGROUND: Hepatocellular carcinoma (HCC) is a highly vascular tumor which is poorly responsiv...
Background Antiangiogenic agents have established efficacy in the treatment of metastatic colorec...
The administration of approved systemic treatments for advanced hepatocellular carcinoma (HCC) is li...
The clinical management of frail, elderly patients affected by colorectal cancer (CRC) remains a sub...
Adrenocortical carcinoma (ACC) is a rare neoplasm characterized by poor prognosis. First-line system...